FarmDroid Field Robot Featured in award-winning “Clarkson’s Farm”: Autonomous Seeding and Weeding Robot in the Spotlight on Prime Video Series
12.6.2026 09:02:28 CEST | news aktuell GmbH | Press release

(Odense, Denmark, June 11, 2026) The hit Prime Video series Clarkson’s Farm features the autonomous field robot FarmDroid FD20 in its latest episode, airing today. Operating on Jeremy Clarkson’s Diddly Squat Farm, the solar-powered robot demonstrates how automation, precision seeding, and mechanical weeding can help farmers improve efficiency while supporting more sustainable crop production.
Clarkson first discovered FarmDroid at LAMMA 2025 while looking for ways to reduce manual labour on the farm. He was impressed by the robot’s ability to carry out both seeding and weed control with exceptional precision.
The FarmDroid FD20 autonomously performs seeding and mechanical weeding with GPS accuracy of up to eight millimetres. By recording the exact position of every seed, it can remove weeds between and within crop rows, reducing chemical use, protecting soil health, and lowering labour requirements.
“Having our robot featured in an internationally successful series like Clarkson’s Farm shows that autonomous field robotics is no longer a technology of the future,” says Kristian Vest Warming, CEO of FarmDroid. “Farmers are facing rising production costs, labour shortages, and increasing sustainability requirements. Autonomous systems can help address these challenges while supporting farm profitability.”
Next-Generation Robot Launch
FarmDroid has also announced a new, larger and more powerful field robot platform. Designed for higher working speeds, greater area coverage, and increased capacity, the new model is scheduled for market launch in September 2026.
Download images here (©FarmDroid)
Contacts
Nikolai Tuborg
Tel:+45 60137568ntu@farmdroid.comImages

Links
About FarmDroid
FarmDroid is the Danish pioneer in solar-powered field robots. The FarmDroid FD20 seeds and weeds a wide variety of crops, using highly precise RTK-GPS. It can increase yields by up to 40% and reduce chemical use by up to 94%.
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
They’re really going for it: emporia launches the first 5G smartphone with a screen warranty15.7.2026 08:40:22 CEST | Press release
Better safe than sorry: the emporiaSMART.8 with Smartcover and rubber protectors
FEV collaborates with Microsoft on efficient AI model approach for in car applications built on NVIDIA9.7.2026 11:05:00 CEST | Press release
Aachen – FEV is collaborating with Microsoft to integrate powerful, in-vehicle Generative AI capabilities built on NVIDIA GPU-accelerated compute and AI model microservices. The cooperation aims to enable multimodal voice, text, and gesture interactions directly in the vehicle – independent of a permanent Internet connection.
Acrobat Studio og Acrobat KI-assistent: den nye generasjonen KI-støttet produktivitet – nå også på norsk8.7.2026 15:08:48 CEST | Press release
SAN JOSE, Calif. - 8. juli 2026 - Adobe utvider tilgjengeligheten til Acrobat Studio og Acrobat KI-assistenten i Norge. Nå er de KI-støttede funksjonene for produktivitet og kreavtivitet også tilgjengelige på norsk, og kan dermed brukes av brukere på lokalt språk. Acrobat Studio kombinerer Adobe Acrobat Pro, Adobe Express Premium og smarte KI-assistenter. Acrobat KI-assistent er også tilgjengelig som et separat tillegg for alle Adobe Acrobat-produkter (Acrobat Reader, Acrobat Standard og Acrobat Pro) – et fleksibelt alternativ for alle som ønsker å bruke KI-støttede funksjoner kun når de arbeider med dokumenter. Begge disse tilbudene gjør det mulig for brukere å raskere samle inn informasjon i PDF-er og Office-dokumenter, opprette innhold og effektivisere arbeidsflyten. Acrobat Studio og Acrobat KI-assistenten markerer et viktig trinn i utviklingen av PDF-filen, som har blitt standarden for viktige dokumenter siden den ble lansert av Adobe i 1993. Acrobat utvikler seg fra et ledende pr
Grünenthal receives FDA Orphan Drug and Rare Pediatric Disease Designations for Tegacorat for the Treatment of Duchenne Muscular Dystrophy8.7.2026 10:37:04 CEST | Press release
Aachen, 08 July 2026 – Grünenthal announced today that its investigational compound tegacorat (GRM-01) received Orphan Drug and Rare Pediatric Disease Designations from the US Food and Drug Administration (FDA) for the treatment of Duchenne muscular dystrophy (DMD).
Grünenthal successfully completes Phase I trial with Nociceptin Receptor (NOP) Agonist29.6.2026 12:28:23 CEST | Press release
The investigational compound has a unique mechanism of action and the potential to become a first-in-class therapy option for the treatment of acute and chronic pain. In a Phase I trial, the investigational compound was demonstrated to be safe and well tolerated. A Phase II trial will commence later this year.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom